Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2025 Filed Aug 15, 2025 21:18 UTC SaleCommon Stock 11,000 $259.29 $2,852,158.10
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 5

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,634.0271

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.12 - $260.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 21:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 99,831 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · derivative · entry 7

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 99,831 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 21:18 UTC SaleCommon Stock 84,571 $259.53 $21,948,677.80
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 4

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,634.0271

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.72 - $260.73, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 21:18 UTC Exercise / conversionCommon Stock 99,831 $98.31 $9,814,385.61
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 3

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,205.0271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:18 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 46,561 $93.88 Strike: $93.88 $4,371,146.68
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · derivative · entry 6

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,561 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:18 UTC SaleCommon Stock 39,251 $262.46 $10,301,629.06
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 2

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,374.0271

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.4100 - $263.9900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:18 UTC Exercise / conversionCommon Stock 46,561 $93.88 $4,371,146.68
Disclosure

SEC source: 0001225208-25-007301 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189,625.0271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 14, 2025.

Read SEC document
August 12, 2025 Filed Aug 12, 2025 20:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,480 $0.00 Strike: $198.30 $0.00
Disclosure

SEC source: 0001225208-25-007206 · doc4.xml · derivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,441

Underlying: Common Stock · 7,480 shares

Expires 2034-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 12, 2025 20:20 UTC SaleCommon Stock 7,036 $262.72 $1,848,493.70
Disclosure

SEC source: 0001225208-25-007206 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,812.521

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.150 - $263-185, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 12, 2025 Filed Aug 12, 2025 20:20 UTC Exercise / conversionCommon Stock 7,480 $198.30 $1,483,284.00
Disclosure

SEC source: 0001225208-25-007206 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,848.521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 75 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006465 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,933

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006466 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,181

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC
keller brettDirector
GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006467 · doc4.xml · nonDerivative · entry 2

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,885

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC
keller brettDirector
GrantCommon Stock 31 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006467 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,871

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006469 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,525

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006469 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,531

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC
Zavery AmitDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006471 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,732

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC
Zavery AmitDirector
GrantCommon Stock 15 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006471 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,720

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006470 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,388

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 9 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006470 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,380

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 16 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006468 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,105.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 51 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006468 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,089.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 16:17 UTC GrantCommon Stock 19 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-006464 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,261

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:12 UTC
keller brettDirector
GrantCommon Stock 130 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005930 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,840

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:12 UTC GrantCommon Stock 180 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005932 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,519

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:12 UTC
Zavery AmitDirector
GrantCommon Stock 130 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005934 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,705

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:12 UTC GrantCommon Stock 130 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005933 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,371

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 16:12 UTC GrantCommon Stock 146 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005931 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,038.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 06, 2025 Filed Jun 6, 2025 18:29 UTC SaleCommon Stock 500 $245.15 $122,574.75
Disclosure

SEC source: 0001225208-25-005752 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,858

Read SEC document
June 06, 2025 Filed Jun 6, 2025 18:34 UTC SaleCommon Stock 4,903 $245.76 $1,204,966.18
Disclosure

SEC source: 0001225208-25-005753 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,263.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.40 - $246.13, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 06, 2025 Filed Jul 28, 2025 21:08 UTC Amendment SaleCommon Stock 500 $245.15 $122,574.75
Disclosure

SEC source: 0001225208-25-006811 · doc4a.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Robert N. Duelks 2007 Revocable Trust

Disclosed balance after: 8,853

Read SEC document
June 04, 2025 Filed Jun 5, 2025 14:35 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,771 $0.00 Strike: $56.37 $0.00
Disclosure

SEC source: 0001225208-25-005725 · doc4.xml · derivative · entry 3

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,771 shares

Expires 2025-11-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 04, 2025 Filed Jun 5, 2025 14:35 UTC SaleCommon Stock 3,556 $243.08 $864,408.48
Disclosure

SEC source: 0001225208-25-005725 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,892.102

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.91 - $243.38, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 04, 2025 Filed Jun 5, 2025 14:35 UTC Exercise / conversionCommon Stock 5,771 $56.37 $325,311.27
Disclosure

SEC source: 0001225208-25-005725 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,448.102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2025 Filed May 28, 2025 15:54 UTC SaleCommon Stock 5,056 $239.55 $1,211,161.26
Disclosure

SEC source: 0001225208-25-005483 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,166.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.4450 - $239.6950, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,107 $0.00 Strike: $88.66 $0.00
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · derivative · entry 6

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,107 shares

Expires 2027-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,801 $0.00 Strike: $107.52 $0.00
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · derivative · entry 5

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,801 shares

Expires 2028-11-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC SaleCommon Stock 2,806 $242.23 $679,706.92
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 4

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,242

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.1595 - $242.5500, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC SaleCommon Stock 2,023 $242.23 $490,038.17
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 3

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,048

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.1595 - $242.5500, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC Exercise / conversionCommon Stock 2,801 $107.52 $301,163.52
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 2

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2025 Filed May 20, 2025 15:38 UTC Exercise / conversionCommon Stock 4,107 $88.66 $364,126.62
Disclosure

SEC source: 0001225208-25-005315 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2025 Filed May 16, 2025 19:37 UTC
Jarkowski Hope M.Chief Legal Officer
SaleCommon Stock 1,069 $240.99 $257,615.00
Disclosure

SEC source: 0001225208-25-005217 · doc4.xml · nonDerivative · entry 1

Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.25

F1 · shares: Consists of shares vested from sign-on time-based restricted stock unit award granted in consideration of awards she forfeited upon her departure from her former employer.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.86 - $241.00, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
May 13, 2025 Filed May 14, 2025 14:32 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 3,607 $237.26 $855,797.54
Disclosure

SEC source: 0001225208-25-005065 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,077

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 07, 2025 Filed May 7, 2025 20:27 UTC
Jarkowski Hope M.Chief Legal Officer
SaleCommon Stock 1,068 $235.23 $251,220.30
Disclosure

SEC source: 0001225208-25-004826 · doc4.xml · nonDerivative · entry 1

Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,070.25

F1 · shares: Consists of shares vested from sign-on time-based restricted stock unit award granted in consideration of awards she forfeited upon her departure from her former employer.

Read SEC document
May 07, 2025 Filed May 7, 2025 20:27 UTC
Stingi Richard JohnCorporate VP and CHRO
SaleCommon Stock 800 $234.81 $187,848.00
Disclosure

SEC source: 0001225208-25-004827 · doc4.xml · nonDerivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,508.799

Read SEC document
April 07, 2025 Filed Apr 8, 2025 16:52 UTC
Carey Thomas PCorporate VP
Tax withholdingCommon Stock 2,462 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004154 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,684

Read SEC document
April 03, 2025 Filed Apr 7, 2025 15:52 UTC GrantCommon Stock 74 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004141 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,358

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F2 · balance_after: Registrant transferred 6,226 shares of common stock owned directly to the Robert N. Duelks 2007 Revocable Trust.

Read SEC document
April 03, 2025 Filed Apr 7, 2025 15:52 UTC GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004136 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,173

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
April 03, 2025 Filed Apr 7, 2025 15:52 UTC
keller brettDirector
GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004137 · doc4.xml · nonDerivative · entry 2

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,710

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
April 03, 2025 Filed Apr 7, 2025 15:52 UTC
keller brettDirector
GrantCommon Stock 30 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004137 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,697

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.